Haizheng Pharmaceutical (600267.SH) subsidiary obtained a new veterinary drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, Haizheng Pharmaceutical (600267.SH) issued an announcement. Recently, Zhejiang Haizheng Animal Health Products Co., Ltd. (“Haizheng Animal Health Insurance Company”), a holding subsidiary of the company, received the approval and issuance of methylprednisolone tablets (for dogs) “New Veterinary Drug Registration Certificate” from the Ministry of Agriculture and Rural Affairs of the People's Republic of China. The new veterinary drug product was officially approved for five new veterinary drugs.

This time, Haizheng Animal Insurance Company's methylprednisolone tablets (for dogs) products obtained five types of “New Veterinary Drug Registration Certificates”, indicating that the above products have complied with the relevant regulations of the “Veterinary Drug Administration Regulations” and “Veterinary Drug Registration Measures”, which is conducive to further promoting the company's strategic layout in the veterinary medicine sector and enhancing the company's market competitiveness.